推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 在圣保羅舉行的第八屆中國(guó)(巴西)農(nóng)用化學(xué)品展覽會(huì)上，巴西農(nóng)學(xué)專(zhuān)家Flávio Hirata表示，中國(guó)公司進(jìn)入巴西市場(chǎng)面臨諸多困難。
近年來(lái)，巴西農(nóng)藥銷(xiāo)售量和銷(xiāo)售額持續(xù)增長(zhǎng)，位居全球農(nóng)藥市場(chǎng)前列。據(jù)估計(jì)，2014年巴西農(nóng)藥銷(xiāo)售額同比增加6%，總額達(dá)122億美元。巴西已經(jīng)成為全球最大也是最重要的農(nóng)化市場(chǎng)。
然而，巴西農(nóng)用化學(xué)品市場(chǎng)太過(guò)于集中，排名前八位的公司占據(jù)了75.3%的市場(chǎng)份額，十二大公司的份額擴(kuò)大到88%，二十大公司則達(dá)到98.57%。其中僅有一家巴西國(guó)有企業(yè)Nortox。新公司在進(jìn)入市場(chǎng)時(shí)勢(shì)必面臨更大挑戰(zhàn)。原因之一在于進(jìn)入巴西市場(chǎng)的難度。Flávio Hirata認(rèn)為最大的障礙在于新產(chǎn)品的登記。獲得登記，市場(chǎng)進(jìn)入和分銷(xiāo)等問(wèn)題都會(huì)迎刃而解。
信用風(fēng)險(xiǎn)也是一大問(wèn)題。非專(zhuān)利農(nóng)藥產(chǎn)品的價(jià)格戰(zhàn)、付款期延長(zhǎng)等因素將降低巴西分銷(xiāo)商和經(jīng)銷(xiāo)商的競(jìng)爭(zhēng)力。考慮到結(jié)算風(fēng)險(xiǎn)，大型生產(chǎn)企業(yè)傾向與大的分銷(xiāo)商合作。其他阻礙因素包括：非專(zhuān)利農(nóng)藥產(chǎn)品領(lǐng)域新涌現(xiàn)的競(jìng)爭(zhēng)對(duì)手，這些公司大多數(shù)為日本公司；持有登記的企業(yè)收購(gòu)銷(xiāo)售公司，將產(chǎn)品直接賣(mài)給最終客戶；多樣化的產(chǎn)品組合、物流、產(chǎn)品質(zhì)量、匯率波動(dòng)、區(qū)域市場(chǎng)的合作關(guān)系等。
